HRTS ETF
Tema Heart & Health ETF
HRTS ETF Overview
HRTS ETF (Tema Heart & Health ETF) is managed by Tema Global Limited with $58.1M in net assets. HRTS expense ratio is 0.75%, holding 47 positions across sectors including Health Care, Financials. Inception date: 2023-11-20.
HRTS performance shows a YTD return of 9.91%. The 1-year return is 21.06%. HRTS dividend yield stands at 1.22%, paid annually.
HRTS top holdings include Eli Lilly & Co (12.8%), Thermo Fisher (5.3%), Merck & Company Inc (4.5%), Roche Holding Ag (Adr) (4.4%), Kodiak Sciences Inc (3.7%). Go to all HRTS holdings, HRTS sectors, or HRTS dividends.
HRTS can be compared against other funds. Use HRTS overlap to find shared positions, or HRTS vs another fund for a side-by-side view. HRTS alternatives are available via the screener, along with tax-loss harvesting opportunities.